Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines

被引:21
作者
Whittle, H
Aaby, P
Samb, B
Cissé, B
Kanteh, F
Soumaré, M
Jensen, H
Bennett, J
Simondon, F
机构
[1] MRC Labs, Banjul, Senegal
[2] ORSTOM, Dakar, Senegal
[3] State Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark
[4] INSERM, U13, Paris, France
[5] Univ Cheikh Anta Diop, Dakar, Senegal
[6] Task Force Child Survival & Dev, Atlanta, GA USA
关键词
hemagglutinin-inhibiting antibodies; high titer measles vaccines; long term follow-up;
D O I
10.1097/00006454-199901000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Few data exist on the persistence of measles antibodies after vaccination of West African infants. Therefore we examined measles antibody titers 5 to 7 years after children in rural Senegal had received high titer Edmonston-Zagreb (EZ-HT), high titer Schwarz (SW-HT) or standard titer Schwarz (SW-STD) measles vaccines in infancy. Methods. Children had received either high titer vaccines at 5 months of age or standard titer at 10 months of age. Finger prick blood samples were tested for measles antibody 5 to 7 years later by the hemagglutinin inhibition test. Results, Persistence of antibody after high titer vaccines was poor with the result that 39 and 50% of the EZ-HT and the SW-HT groups had low titers of hemagglutinin inhibition measles antibodies (less than or equal to 125 mIU/ml), Nineteen percent of the children in the SW-STD group had low titers which is a lower prevalence than in the high titer groups [relative risk (95% confidence intervals), 0.05 (0.28 to 0.88) vs. EZ-HT; relative risk, 0.38 (0.22 to 0.66) vs. SW-HT], Geometric mean (95% confidence interval) antibody titers in children with detectable values were 616 (435 to 871) in the EZ-HT, 1106 (616 to 1866) in the SW-HT and 1271 (871 to 1741) mIU/ml in the SW-STD groups, respectively. Multivariant regression analysis showed that mean titers were 2.00 (1.03 to 3.89) times higher for children with low prevaccination antibody titers (less than or equal to 125 mIU/ml) and 3.06 (1.90 to 4.94) times higher if blood was collected in the rainy season. Interpretation. Given the rapid decline in antibody titers over a 5- to 6-year period in an area where measles vaccine coverage was high, it seems likely that multiple dose immunization schedules will be needed in the future to maintain protective antibody concentrations (>125 mIU/ml) in West Africa. The role of subclinical boosting by exposure to natural measles and the possible role of malaria, which increases immunoglobulin turnover, in influencing long term antibody persistence after vaccination deserve further investigation.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 22 条
[1]   MEASLES INCIDENCE, VACCINE EFFICACY, AND MORTALITY IN 2 URBAN AFRICAN AREAS WITH HIGH VACCINATION COVERAGE [J].
AABY, P ;
KNUDSEN, K ;
JENSEN, TG ;
THARUP, J ;
POULSEN, A ;
SODEMANN, M ;
DASILVA, MC ;
WHITTLE, H .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1043-1048
[2]  
AABY P, 1994, B WORLD HEALTH ORGAN, V72, P761
[3]   LONG-TERM SURVIVAL AFTER EDMONSTON-ZAGREB MEASLES VACCINATION IN GUINEA-BISSAU - INCREASED FEMALE MORTALITY-RATE [J].
AABY, P ;
KNUDSEN, K ;
WHITTLE, H ;
LISSE, IM ;
THAARUP, J ;
POULSEN, A ;
SODEMANN, M ;
JAKOBSEN, M ;
BRINK, L ;
GANSTED, U ;
PERMIN, A ;
JENSEN, TG ;
ANDERSEN, H ;
DASILVA, MC .
JOURNAL OF PEDIATRICS, 1993, 122 (06) :904-908
[4]   Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal [J].
Aaby, P ;
Samb, B ;
Simondon, F ;
Knudsen, K ;
Seck, AMC ;
Bennett, J ;
Markowitz, L ;
Whittle, H .
VACCINE, 1996, 14 (03) :226-229
[5]   PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE [J].
ALBRECHT, P ;
ENNIS, FA ;
SALTZMAN, EJ ;
KRUGMAN, S .
JOURNAL OF PEDIATRICS, 1977, 91 (05) :715-718
[6]   MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS [J].
CHEN, RT ;
MARKOWITZ, LE ;
ALBRECHT, P ;
STEWART, JA ;
MOFENSON, LM ;
PREBLUD, SR ;
ORENSTEIN, WA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1036-1042
[7]  
CISSE B, IN PRESS AM J EPIDEM
[8]   GAMMA-GLOBULIN AND ACQUIRED IMMUNITY TO HUMAN MALARIA [J].
COHEN, S ;
CARRINGTON, S ;
MCGREGOR, IA .
NATURE, 1961, 192 (480) :733-&
[9]  
CUTTS FT, 1995, BIOLOGICALS, V23, P95
[10]   Measles elimination in the Americas - Evolving strategies [J].
deQuadros, CA ;
Olive, JM ;
Hersh, BS ;
Strassburg, MA ;
Henderson, DA ;
BrandlingBennett, D ;
Alleyne, GAO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :224-229